These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 214127)

  • 21. Variations in endogenous phosphodiesterase activator content of rat aorta.
    Lugnier C; Ilien B; Stoclet JC
    Eur J Pharmacol; 1978 Dec; 53(1):109-12. PubMed ID: 216558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The response of cyclic 3',5'-AMP and cyclic 3',5'-GMP phosphodiesterases to experimental diabetes.
    Perez de Gracia B; Rhoads AR; West WL
    Experientia; 1980 Jul; 36(7):824-5. PubMed ID: 6249634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
    Hidaka H; Endo T
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
    [No Abstract]   [Full Text] [Related]  

  • 24. Reconsideration of the multiple cyclic nucleotide phosphodiesterases in bovine heart.
    Donnelly TE
    Biochem Biophys Res Commun; 1978 Jun; 82(3):964-70. PubMed ID: 212032
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
    Kuo JF; Shoji M; Brackett NL; Helfman DM
    J Cyclic Nucleotide Res; 1978 Dec; 4(6):463-74. PubMed ID: 85641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic nucleotide phosphodiesterase from a particulate fraction of rat heart. Solubilization and characterization of a single enzymatic form.
    Prigent AF; Némoz G; Yachaoui Y; Pageaux JF; Pacheco H
    Biochem Biophys Res Commun; 1981 Sep; 102(1):355-64. PubMed ID: 6272794
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of theophylline and other drugs on rabbit renal cyclic nucleotide phosphodiesterase, 5'-nucleotidase and adenosine deaminase.
    Fredholm BB; Hedqvist P; Vernet L
    Biochem Pharmacol; 1978; 27(24):2845-50. PubMed ID: 216371
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclic nucleotide phosphodiesterase assay technology.
    MacKenzie SJ; Hastings SF; Wells C
    Curr Protoc Pharmacol; 2010 Jun; Chapter 3():Unit 3.12. PubMed ID: 22294369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of rat heart cyclic nucleotide phosphodiesterase on column of immobilized phenylbutenolide inhibitor.
    Prigent AF; Némoz G; Pacheco H
    Biochem Biophys Res Commun; 1980 Aug; 95(3):1080-9. PubMed ID: 6251827
    [No Abstract]   [Full Text] [Related]  

  • 30. Rat brain and lung cyclic nucleotide phosphodiesterases: different responses to cromoglycate [proceedings].
    Saeed SA; Butt NM; Taylor WA
    Biochem Soc Trans; 1979 Oct; 7(5):1037-8. PubMed ID: 229020
    [No Abstract]   [Full Text] [Related]  

  • 31. Stimulation of rat liver cyclic 3':5'-nucleotide phosphodiesterase by cyclic GMP is dependent on enzyme concentration.
    Guan WR; Cheung WY
    Arch Biochem Biophys; 1980 Oct; 204(1):191-8. PubMed ID: 6252844
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclic nucleotide phosphodiesterase activity in cardiac and vascular smooth muscle of the spontaneously hypertensive rat.
    Taylor JE; Shirachi DY
    Proc West Pharmacol Soc; 1977; 20():307-10. PubMed ID: 197543
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
    Nemoz G; Prigent AF
    Ann Pharm Fr; 1984; 42(2):99-112. PubMed ID: 6091520
    [No Abstract]   [Full Text] [Related]  

  • 34. A reverse-phase HPLC method for cyclic nucleotide phosphodiesterases activity and classification.
    Spoto G; Berardi S; Ajerba G; De Laurentiis V
    Adv Exp Med Biol; 1994; 370():815-20. PubMed ID: 7661030
    [No Abstract]   [Full Text] [Related]  

  • 35. Protein activator of cyclic AMP phosphodiesterase and cyclic nucleotide phosphodiesterase in bovine retina and bovine lens. Activity, subcellular distribution and kinetic parameters.
    Liu YP; Schwartz HS
    Biochim Biophys Acta; 1978 Sep; 526(1):186-93. PubMed ID: 210826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
    Ilien B; Ruckstuhl M; Landry Y
    J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of cyclic nucleotide phosphodiesterase activity.
    Vaughan M; Danello MA; Manganiello VC; Strewler GJ
    Adv Cyclic Nucleotide Res; 1981; 14():263-71. PubMed ID: 6169258
    [No Abstract]   [Full Text] [Related]  

  • 38. [Properties of cyclic nucleotide phosphodiesterase from lingual taste papillae].
    Ostretsova IB
    Biokhimiia; 1978 Jun; 43(6):1037-44. PubMed ID: 27246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationships.
    Van Inwegen RG; Salaman P; St Georgiev V; Weinryb I
    Biochem Pharmacol; 1979 Apr; 28(8):1307-12. PubMed ID: 87199
    [No Abstract]   [Full Text] [Related]  

  • 40. Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates.
    Kincaid RL; Manganiello VC
    Methods Enzymol; 1988; 159():457-70. PubMed ID: 2842611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.